Discussão sobre este post

Avatar de User
Avatar de Elizabeth Woodworth

Superb, Filipe! The acrobatic pilot is one of the best epidemiologists I know! 👏

Expand full comment
Avatar de Tom Hogan

You phrase your argument in an interesting way.

Smoking gun

In January, 2020, the CDC recommending treating high risk influenza patients early with antivirals--even before lab results came back.

In February, 2020, the FDA recommended withholding early treatment of the antiviral HCQ from everyone, including high risk covid patients--HCQ was recommended only for hospitalized patients.

This does not compute. Do the CDC and FDA not talk to each other? Why should early treatment with the antiviral HCQ be withheld from high risk patients in the case of covid, but antivirals should not be withheld from high risk patients in the case of influenza? Influenza, which is supposedly far less deadly than covid, was to be treated on suspicion, but covid was NOT to be treated on suspicion???

Where has the FDA ever issued a rationale for this recommendation? And why did the CDC never question the FDA's recommendation?

I agree with you. I don't think that the problem with the public health organizations is incompetence.

pharma $$$

Expand full comment
Mais 29 comentários...

Nenhuma publicação